Mode
Text Size
Log in / Sign up
Phase 3 N=302 Randomized Single-blind Prevention

The MOM Program: 5 Year Follow-up Study of a Home Visiting Program at The Children's Hospital of Philadelphia

Child Development

Enrolled (actual)
302
Serious AEs
0.0%
Results posted
Jul 2010
Primary outcome: Primary: Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III) — 86.5; 87.4 Scores on a scale — p=0.59

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Home visiting professional support model (Behavioral); Control (Other)
Age
Pediatric · 4+ yrs
Sex
All
Sponsor
Children's Hospital of Philadelphia
Primary completion
Feb 2007

Outcome Measures

OutcomeResultp-value
PRIMARY
Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III)
86.5; 87.4 0.59
PRIMARY
Child Behavior Checklist Internalizing Scale at 5 Years of Age, Percentage of Participants
8; 11 0.72
PRIMARY
Child Behavior Checklist Externalizing Scale, Percentage of Abnormality in Participants
3; 12 <0.01 sig
PRIMARY
Child Behavior Checklist Aggressive Subscale, Percentage of Abnormality in Participants
4; 12 <0.05 sig
PRIMARY
Child Behavior Checklist Attention Subscale, Percentage of Abnormality in Participants
7; 8 0.64

Summary

The purpose of the MOM Program Continuation is to promote child development by helping families become more competent in accessing and using available health, developmental and educational resources. The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment. The Intervention consists of frequent phone calls and home visits to encourage mothers to have their babies immunized on schedule and to participate in needed developmental and educational services. The program seeks to fill the gap between children's need for services and mothers' ability to assure their children's participation in those services.

Eligibility Criteria

Inclusion Criteria: Previous enrollment in The MOM Program; child age of 5 years (plus or minus 3 months); willingness to come to office for follow-up assessment visit; parental consent and child assent. Exclusion Criteria: None.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00231179). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search